Biotech / Medical
An SI Board Since December 2006
Posts SubjectMarks Bans
10 2 0
Emcee:  nigel bates Type:  Moderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
10Galapagos initiates Phase I study for JAK inhibitor GLPG0634, acquires full rightnsaf8/8/2010
9Galapagos enters into global alliance with Janssen Pharmaceutica on rheumatoid nigel bates10/24/2007
8ProStrakan and Galapagos receive additional milestone payment in antibody collabnigel bates9/27/2007
7Galapagos announces achievement of milestones totaling €3.2 million in osteoarthnigel bates3/30/2007 Galapagos announces 2006 full year results Friday March 2, 2:09 ascaram(o)uche3/2/2007
5Rosenwald, trying to stick it to a new generation of biotech investors.scaram(o)uche2/1/2007
4Galapagos announces PPAR-delta commercial license agreement with Hillcrest Theranigel bates2/1/2007
3Galapagos reports 2006 financial update, drug discovery advancements and changesnigel bates1/12/2007
2Mechelen, Belgium; 3 January 2007 - Galapagos NV (Euronext & LSE: GLPG) annonigel bates1/3/2007
1Galapagos acquires ProSkelia from ProStrakan and raises €31 million Creates drugnigel bates12/22/2006
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News - See Terms of Use.